Virtus ETF Advisers’s C4 Therapeutics CCCC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-12,350
| Closed | -$38.8K | – | 443 |
|
|
2023
Q1 | $38.8K | Sell |
12,350
-4,752
| -28% | -$14.9K | 0.02% | 438 |
|
|
2022
Q4 | $101K | Sell |
17,102
-2,203
| -11% | -$13K | 0.05% | 439 |
|
|
2022
Q3 | $169K | Buy |
19,305
+136
| +0.7% | +$1.19K | 0.07% | 334 |
|
|
2022
Q2 | $145K | Buy |
19,169
+13,894
| +263% | +$105K | 0.05% | 322 |
|
|
2022
Q1 | $128K | Sell |
5,275
-314
| -6% | -$7.62K | 0.06% | 251 |
|
|
2021
Q4 | $180K | Buy |
5,589
+546
| +11% | +$17.6K | 0.07% | 246 |
|
|
2021
Q3 | $225K | Sell |
5,043
-269
| -5% | -$12K | 0.1% | 239 |
|
|
2021
Q2 | $201K | Buy |
+5,312
| New | +$201K | 0.08% | 341 |
|